How can endothelial function be assessed?

Measuring Endothelial Function

Yes, endothelial function can be measured using flow-mediated dilation (FMD) of the brachial artery via high-resolution ultrasound—the gold standard non-invasive technique that assesses endothelium-dependent vasodilation in response to increased shear stress. 1

Primary Method: Flow-Mediated Dilation (FMD)

Equipment Requirements

• Use a high-resolution ultrasound system with a linear array transducer of 7–12 MHz frequency to visualize the brachial artery and measure diameter changes 1
• A standard blood pressure cuff for arterial occlusion is required 2
• ECG gating during image acquisition optimizes measurement timing within the cardiac cycle 2

Patient Preparation

• Patients must fast for 4–6 hours and avoid caffeine, high-fat foods, vitamin C, and tobacco for the same period before testing 1
• Position the patient supine with the arm comfortably supported and extended 1
• Note that menstrual cycle phase may affect results in women 1

Measurement Protocol

Baseline Imaging

• Image the brachial artery in the longitudinal plane 5–10 cm above the antecubital fossa where clear anterior and posterior intimal interfaces are visible 2, 1
• Record baseline arterial diameter at end-diastole (using the R-wave on ECG) to avoid confounding from vessel compliance changes 2
• Obtain baseline blood flow velocity using pulsed Doppler 2

Cuff Occlusion

• Place the cuff on either the upper arm or forearm and inflate to at least 50 mm Hg above systolic pressure for exactly 5 minutes 2, 1
• Upper-arm occlusion produces larger percent diameter changes (greater flow stimulus from recruiting more resistance vessels) but is technically more challenging due to artery collapse and tissue shift 2
• Forearm occlusion is technically easier but yields smaller changes 2
• The 5-minute duration is optimal—comparable results to 10 minutes but better tolerated 2

Post-Deflation Assessment

• Begin continuous recording 30 seconds before cuff release and continue for 2 minutes after deflation 2, 1
• Obtain pulsed Doppler signal within 15 seconds of cuff release to assess hyperemic velocity 2
• Peak arterial dilation typically occurs at approximately 60 seconds after cuff release (or 45–60 seconds after peak hyperemic flow) 2, 1
• Approximately 70% of the dilation observed at 1 minute is attributable to nitric oxide synthesis 1

Measurement Standards

• Measure diameter at the lumen-intima interface on both near and far walls using perpendicular insonation angle 2, 1
• Measure along a longitudinal segment rather than single-point measurements to reduce variability 2
• Express FMD as percent change from baseline diameter: (post-stimulus diameter - baseline diameter) / baseline diameter × 100 2, 1
• Report baseline diameter, absolute change, and percent change to account for baseline diameter effects 2

Technical Limitations

• Arteries smaller than 2.5 mm are difficult to measure accurately; vessels larger than 5.0 mm show less perceptible vasodilation 2, 1
• The technique can be applied to radial, axillary, and superficial femoral arteries 2
• FMD is technically challenging and requires extensive training and standardization 3

Complementary Assessment: Endothelium-Independent Vasodilation

Nitroglycerin Test

• Wait at least 10 minutes after FMD measurement to allow the artery to return to baseline 2
• Administer 0.4 mg sublingual nitroglycerin spray or tablet to assess smooth muscle function independent of endothelial nitric oxide production 2, 1
• Peak vasodilation occurs 3–4 minutes after nitroglycerin administration—record continuously during this period 2, 1
• Contraindications include clinically significant bradycardia or hypotension 2, 1

Alternative Non-Invasive Methods

Peripheral Arterial Tonometry (PAT)

• Finger plethysmography evaluates pulse wave amplitude changes during reactive hyperemia, reflecting microcirculatory endothelial function rather than conduit artery function 3, 4, 5
• Easier to perform than FMD but measures different vascular territories (small arteries and microcirculation versus large conduit arteries) 5
• Requires consensus on measurement protocols and establishment of reference values before widespread clinical adoption 3

Digital Thermal Monitoring (DTM)

• Assesses temperature changes in fingertips during reactive hyperemia 4
• Less established than FMD or PAT 4

Other Vascular Assessment Tools

• Carotid intima-media thickness (cIMT), ankle-brachial index (ABI), pulse wave velocity (PWV), and arterial stiffness measures provide complementary information about vascular health but do not directly measure endothelial function 6, 4

Invasive Methods (Reference Standard)

• Coronary epicardial and microvascular function testing via intracoronary acetylcholine infusion remains the gold standard but is invasive, time-consuming, and expensive 3
• Limited to research settings and high-risk patients 3

Quality Control and Reproducibility

Expected Values

• Acceptable reproducibility shows a mean difference of 2–3% in FMD over time, with baseline vasodilation approximately 10% 1
• The minimal detectable improvement with an intervention is an absolute FMD increase of 1.5–2% 1

Common Pitfalls to Avoid

• Inconsistent hyperemic flow stimulus between measurements confounds results—always report peak hyperemic flow velocities 1
• Unaccounted changes in baseline diameter between pre- and post-intervention measurements 1
• Poor image quality from inadequate transducer positioning or patient movement 2, 1
• Failure to control confounding factors: diet, medications, time of day, temperature 1
• Measuring during end-systole rather than end-diastole introduces variability from vessel compliance changes 2

Study Design Considerations

• For crossover trials, 20–30 participants are typically sufficient; parallel-group designs require 40–60 participants 1

Clinical Context

There is no single ideal method for measuring endothelial function 3. FMD provides the most validated non-invasive assessment of conduit artery endothelial function, but it requires significant technical expertise and standardization 3, 7. The European Society of Cardiology recommends adopting a consensus methodology for FMD universally to minimize technical variation and establishing reference values for different populations 3. Endothelial dysfunction serves as an early marker of atherosclerotic disease and integrates cardiovascular risk factor burden, making its measurement valuable for risk stratification 5.